| Sep 22, 2025 |
Sep 23, 2025 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
28.8
|
-2,227
|
-9.16%
|
✓
|
$173.6K |
| Sep 10, 2025 |
Sep 11, 2025 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
5.0
|
-20,000
|
-45.14%
|
✓
|
$1.5M |
| Feb 23, 2025 |
Feb 24, 2025 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
42.5
|
-3,601
|
-10.14%
|
✗
|
$208K |
| Feb 15, 2025 |
Feb 18, 2025 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
40.0
|
-15,752
|
-14.20%
|
✗
|
$918.2K |
| Jul 22, 2024 |
Jul 23, 2024 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
22.5
|
-5,000
|
-13.90%
|
✓
|
$269.7K |
| Jun 26, 2024 |
Jun 28, 2024 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
5.0
|
-30,000
|
-39.25%
|
✓
|
$1.6M |
| Feb 16, 2024 |
Feb 20, 2024 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
42.5
|
-5,601
|
-16.43%
|
✗
|
$202.2K |
| Feb 15, 2024 |
Feb 16, 2024 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
46.3
|
-686
|
-6.05%
|
✗
|
$24.6K |
| Feb 10, 2024 |
Feb 13, 2024 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
42.5
|
-1,477
|
-12.77%
|
✗
|
$52.4K |
| Feb 16, 2023 |
Feb 21, 2023 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
42.5
|
-2,525
|
-21.78%
|
✗
|
$124.4K |
| Feb 15, 2023 |
Feb 17, 2023 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
46.3
|
-621
|
-8.72%
|
✗
|
$30.6K |
| Feb 10, 2023 |
Feb 14, 2023 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
42.5
|
-2,073
|
-15.83%
|
✗
|
$101.4K |
| Nov 15, 2022 |
Nov 16, 2022 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
20.0
|
-5,000
|
-55.28%
|
✗
|
$269.1K |
| Feb 15, 2022 |
Feb 17, 2022 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
46.3
|
-433
|
-4.57%
|
✗
|
$14.9K |
| Feb 10, 2022 |
Feb 14, 2022 |
HALOZYME THERAPEUTICS, INC.
|
CFO |
Sell |
42.5
|
-1,958
|
-8.13%
|
✗
|
$67.5K |